Joan Antoni Gómez-Hospital

Watch time: 3h 22m 24s (23 videos)

About

Mechanical circulatory support has emerged as an important therapy for advanced heart failure. These devices significantly improve survival and quality of life and should be considered in every patient with end-stage heart failure with reduced ejection fraction who has no other life-limiting diseases.

Devices, such as implantable cardioverter-defibrillators (ICDs), and novel pacing technologies, including cardiac resynchronisation therapy (CRT), have helped to complement goal-directed medical therapy and positively impact prognosis in these patients, as demonstrated in multiple high-quality clinical trials.

Articles

Tricuspid Regurgitation Therapy

Published:

28 September 2023

Citation:

European Cardiology Review 2023;18:e55.

Comment on Leadless Pacemakers

Published:

18 August 2023

Citation:

European Cardiology Review 2023;18:e50.

Transvenous Lead Extraction: Work in Progress

Published:

19 June 2023

Citation:

European Cardiology Review 2023;18:e44.

Highlights from the ESC Congress 2021

Published:

13 May 2022

Citation:

European Cardiology Review 2022;17:e12.